Item 7.01. Regulation FD Disclosure.

Monte Rosa Therapeutics, Inc. (the "Company") will be conducting meetings with investors attending the 40th Annual J.P. Morgan Healthcare Conference (the "Conference"), which is taking place virtually beginning on January 10, 2022. As part of these meetings, the Company will deliver its revised corporate presentation, furnished to this report as Exhibit 99.1 and which is incorporated herein by reference (the "Materials"). The Company will also present a portion of the Materials at the Conference.

The information in this report furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Item 7.01 of this report.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits



Exhibit No.       Description

99.1                Corporate presentation furnished by Monte Rosa Therapeutics,
                  Inc. on January 10, 2022

104               Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses